Viewing Study NCT03311503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:15 PM
Ignite Modification Date: 2026-02-25 @ 10:05 PM
Study NCT ID: NCT03311503
Status: RECRUITING
Last Update Posted: 2025-12-11
First Post: 2017-10-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Sponsor: David Williams
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Severe Combined Immunodeficiency, X Linked View
None Gene Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lentiviral View
None Gene therapy View
None busulfan View